NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









StrainX Bioworks

StrainX Bioworks

Private
BhopalHealthcare & Life Scienceshttps://www.strainx.in/

Last Round

Series A

May 25, 2026

Total Funding Raised

$13M

Company Overview

StrainX Bioworks is a biotechnology company that uses synthetic biology and precision fermentation to develop sustainable, high-value biomolecules for the food, nutraceutical, and beauty industries.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Smart Manufacturing, Fashion & Beauty, Sustainable Materials

Business Model

B2B

Customer Profile

Data as a Service, Services & Consulting

AI Layer

Non-AI

Keywords

precision fermentationsynthetic biologybiomanufacturingalternative proteinsclean-label ingredientsstrain engineeringbioactive moleculesbiotech ingredientsfood techcellular agriculturecosmetic ingredientsnutraceuticalsfermentation platformsustainable ingredientsbiotech manufacturing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

StrainX Bioworks Comparables

Compare StrainX Bioworks with similar companies based on industry and business-model similarity.

StrainX Bioworks comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Cauldron
81%
Fermbox Bio
79%
Conagen
79%

StrainX Bioworks Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AMay 25, 2026

Key People

Founding team and executive leadership

Akshay Mittal

Founder & CEO

Founding Team

StrainX Bioworks Investors

Notable investors and investment history

StrainX Bioworks investors
InvestorRounds
Leo CapitalSeries A
Good StartupSeries A
Dholakia VenturesSeries A
Prime Venture PartnersSeries A
Sun Icon VenturesSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 15, 2025

    Grew 200% QoQ from 2 to 6 employees.

  • May 11, 2025

    Grew 400% QoQ from 1 to 5 employees.

StrainX Bioworks Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

StrainX Bioworks Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about StrainX Bioworks's valuation, stock price, and market status.

Firmographic Details

HeadquartersBhopal
Employee Range38
Year Founded2023
Last FundingMay 25, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.